The Record - For physicians and other health care providers to share with their office staffs Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article

May 2016

Blue Cross setting new quantity limits for Enbrel®, Humira®, Actemra® and Cimzia®

On June 1, 2016, Blue Cross Blue Shield of Michigan will implement new quantity limits for the following drugs:

Drug

Strength

Quantity covered for 30 days

Enbrel®                   

25 mg multiple-use vial   

1 package (4 vials)

25 mg/0.5 ml single-use prefilled syringe

1 package (4 syringes)

50 mg/ml single-use prefilled auto injector

1 package (4 auto injectors)

50 mg/ml single-use prefilled syringe

1 package (4 syringes)

Humira®

10 mg/0.2 ml single-use prefilled syringe

1 package (2 syringes)

20 mg/0.4 ml single-use prefilled syringe

1 package (2 syringes)

40 mg/0.8 ml single-use prefilled syringe

2 packages (4 syringes)

Humira® pen

40 mg/0.8 ml single-use prefilled pen

2 packages (4 pens)

Humira® pen - pediatric

  • Crohn’s disease

40 mg/0.8 ml single-use prefilled pen
(starter pack** with 3 pens)

2 packages (6 pens) per 365 days

40 mg/0.8 ml single-use prefilled pen
(starter pack** with 6 pens)

2 packages (12 pens) per 365 days

Humira® pen

  • Crohn’s disease
  • Ulcerative colitis
  • Hidradenitis suppurativa

40 mg/0.8ml single-use prefilled pen
(starter pack**)

2 packages (12 pens) per 365 days

Humira® pen

  • Psoriasis


      

40 mg/0.8 ml single-use prefilled pen
(starter pack**)

2 packages (8 pens) per 365 days

Actemra®

162 mg/0.9ml single-use prefilled syringe

4 packages (4 syringes)

Cimzia®

200 mg/ml single-use prefilled syringe

1 package (2 syringes)

Cimzia®

200 mg/ml single-use prefilled syringe
(starter pack**)

2 packages (12 syringes) per 365 days

**Starter packs are limited to a maximum of two packages per year.

The quantity limits only affect our commercial (non-Medicare) members who have Blue Cross pharmacy benefits that include quantity limits. They don’t apply to MESSA members.

If necessary, you can request an override of the quantity limits for your patients. The request should include documentation stating that the amount prescribed is medically necessary. To get a form for a quantity limit override, log in as a provider at bcbsm.com or call the Pharmacy Services Clinical Help Desk at 1-800-437-3803.

Our goal is to provide our members with safe, high-quality prescription drug therapies. Enbrel®, Humira®, Actemra® and Cimzia® are high-cost specialty medications. To help our members maintain lower premiums, we’re attempting to limit waste or overutilization of expensive medications. The quantity limits align with dosing guidelines approved by the U.S. Food and Drug Administration to minimize potentially unsafe drug use by our members.

We sent letters in April to notify members who may be affected by these quantity limit changes. The letters encourage members to discuss treatment options with their physicians.

If you have any questions about this program, call the Pharmacy Services Clinical Help Desk at 1-800-437-3803.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2015 American Medical Association. All rights reserved.